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RFamides (RFa) are neuropeptides involved in many different physiological processes in ver-
tebrates, such as reproductive behavior, pubertal activation of the reproductive endocrine
axis, control of feeding behavior, and pain modulation. As research has focused mostly on
their role in adult vertebrates, the possible roles of these peptides during development are
poorly understood. However, the few studies that exist show that RFa are expressed early
in development in different vertebrate classes, perhaps mostly associated with the central
nervous system. Interestingly, the related peptide family of FMRFa has been shown to
be important for brain development in invertebrates. In a teleost, the Japanese medaka,
knockdown of genes in the Kiss system indicates that Kiss ligands and receptors are vital
for brain development, but few other functional studies exist. Here, we review the litera-
ture of RFa in early vertebrate development, including the possible functional roles these
peptides may play.
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INTRODUCTION
Neuropeptides with an arginine (R) and an amidated phenylala-
nine (F)-motif at its C-end (called RFamides or RFa) were first
described in mollusks in the 70s [FMRFamide (FMRFa)] (1).
Soon after, an RFa was also found in a vertebrate (2). Since then,
many RFa have been identified in different vertebrate species,
with the most recent group of vertebrate RFa found as late as
2002 (3). Vertebrate RFa are currently divided into five groups:
(i) neuropeptide FF (NPFF) group or PQRFa group, consisting of
NPFF, neuropeptide AF (NPAF), and neuropeptide SF (NPSF); (ii)
prolactin-releasing peptide (PrRP) group, consisting of PrRP20
and PrRP31, crucian carp RFamide (C-RFa), and salmon RFa;
(iii) gonadotropin-inhibitory hormone (GnIH) group, includ-
ing mammalian RFa-related peptides (RFRP-1 and RFRP-3), frog
growth hormone-releasing peptide (fGRP), and goldfish LPXR-
Famide peptide; (iv) kisspeptin group also known as metastin;
and finally (v) 26RFa/QRFP, including the peptides 26RFa and
43RFa (QRFP) (4, 5). These peptides have been studied in several
different physiological contexts, and are found to have a role in a
wide range of processes in vertebrates, as in reproductive behavior
and in control of the reproductive axis (6), in pain modulation
(7), and in control of feeding (8). However, much more research
is needed to fully comprehend the function of RFa in different
processes.
Interestingly, FMRFa are expressed in the nervous system at
very early developmental stages in several phyla of metazoans, as
mollusks (cephalopods and gastropods) (9, 10), cnidarians (11),
and annelids (a polychete) (12). This may indicate an evolutionary
ancient role of FMRFa in the development of the nervous system.
It has also been shown that regeneration of flatworm anterior
body fragments are stimulated by RFa (13), further supporting a
role for RFa in development of tissues in lower metazoans. Also in
vertebrates, the developmental studies of RFa show exciting results.
Common for all the peptides is that they seem to be expressed at
a very early stage in most vertebrate species studied, ranging from
fishes to mammals. It seems that RFa could have important roles in
development not yet discovered. This review aims to sum up what
is known about the temporal and spatial expression pattern, as
well as potential functional roles of the different RFa in vertebrate
development, using a comparative approach.
NPFF GROUP
The first RFa to be identified in vertebrates was NPFF (also known
as F8F-amide) and NPAF (2). Also belonging to this group is the
peptide NPSF, and all three peptides are transcribed from the same
gene in mammals (5). Genes encoding for NPFF have been identi-
fied in many different vertebrate classes, from hagfish to mammals,
and members of this group bind to the receptor NPFFR2 (also
called GPR74, NPFF2) (5).
Few studies have investigated the expression, location, or func-
tion of NPFF during development. However, one study in teleosts
(14), one in amphibians (15), one in birds (16), and two studies
in mammals (17, 18) show that this peptide is expressed early in
embryonic life in different vertebrate classes. In addition, many
studies have used polyclonal antibodies against FMRFa that also
seem to label the NPFF peptide (see later, and Table 1), provid-
ing additional information regarding NPFF expression patterns.
Below, a brief description of where NPFF is expressed in adult
vertebrates is included, followed by a description of the studies
performed during development.
NPFF IN ADULT VERTEBRATES
In adult agnathans, NPFF RFa has been found expressed in the
hypothalamus. Furthermore, it has been shown that NPFF stim-
ulates the expression of the gonadotropin-β gene in the pituitary
of hagfish, which suggests that NPFF can have a role in control
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Table 1 | Overview of studies of NPFF in vertebrate development.
RFa and/or
receptors
Species Method Antibody
(or radioligand)
Embryonic
stages
Location of
peptide/mRNA
in early developing
central nervous
system
Putative
functions
in early
development
Reference
NPFF Zebrafish
(Danio rerio)
ISH – 24, 30, 36 hpf, 2,
3, 4, 7 dpf, adult
Exclusively in large cells
of the developing
terminal nerve
– (14)
FMRFa
(NPFF+ ?)
Zebrafish and
sterlet
(Acipenser
ruthenus)
ir Pol 1:1000-1:20000
rabbit anti-FMRFa
(Phoenix/Incstar)
24–60 hpf and
5 dpf zebrafish,
juvenile sterling
Developing terminal
nerve, hyp
Involvement in
brain functions
(19)
FMRFa
(NPFF+ ?)
Brown trout
(Salmo trutta
fario)
ir Pol 1:500 rabbit
anti-FMRFa
(Chemicon/Incstar)
Embryos, alevins,
fry
Developing terminal
nerve, hyp (NAPv,
NPPv)
Regulation of
neural centers
related to
analgesia, feeding
(20)
FMRFa
(NPFF+ ?)
Lungfish
(Neoceratodus
forsteri )
ir Pol 1:10000
anti-FMRFa, Phoenix
Just before
hatching to
juvenile stages
Paraventricular organ in
hyp, terminal nerve at
hatching
– (21)
FMRFa
(NPFF+ ?)
Frog (Rana
esculenta)
ir Pol FMRFa
antiserum (Peninsula
labs)
Posthatching tel and diencephalon
(newly hatched)
Modulation of
GnRH-neurons?
(22)
NPFF African clawed
frog (Xenopus
laevis)
ir Pol 1:1000 rabbit
anti-NPFF serum
(from Dr. H.Y.T. Yang,
Elisabeth’s Hospital,
Washington, DC,
USA)
E30–45, and
through
metamorphosis
Olfactory bulbs and
ventral tel, hyp, NTS,
and spinal cord in
embryo
Regulation of
α-MSH release?
Spinal
embryogenesis?
(15)
FMRFa
(NPFF+ ?)
Toad (Bufo
bufo)
ir Pol 1:30000 rabbit
anti-FMRFa
(Phoenix)
Embryonic and
larval stages
Suprachiasmatic area in
embryo (stage III6).
Olfactory bulb, tel,
suprachiasmatic hyp in
early larvae
Neuromodulator/
neurohormone
during
development
(23)
FMRFa
(NPFF+ ?)
Skink
(Chalcides
chalcides)
ir Pol 1:10000,
1:30000 anti-FMRF
(Phoenix)
7 –70 dpf
(birth)-neonatal
Fore- and hindbrain
(terminal nerve, OB,
hyp lateral preoptic
area, suprachiasmatic
area, and NAPv), MRF
(35 dpf), plus NTS and
vagus nerve close to
birth
Regulation of
blood pressure?
Control of
pituitary?
(24)
FMRFa
(NPFF+ ?)
Chicken
(Gallus
domesticus)
ir Pol 1:4000 FMRFa
antiserum (Peninsula
labs)
E11–19 TN – (25)
(Continued)
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Table 1 | Continued
RFa and/or
receptors
Species Method Antibody
(or radioligand)
Embryonic
stages
Location of
peptide/mRNA
in early developing
central nervous
system
Putative
functions
in early
development
Reference
FMRFa
(NPFF+ ?)
Japanese quail
(Coturnix
japonica via)
ir 1:5000 Anti-FMRFa
(26), 1:3000
anti-FMRFa
(Cambridge
Research
Biochemicals),
1:3000 anti-bovine
F8F (2)
E2.5–12 Fibers in diencephalon
(hyp), brain stem,
olfactory nerve, and cell
bodies in septum at
early stages. OB at later
stages
– (16)
FMRFa
(NPFF+ ?)
African clawed
frog
ir Pol 1:1000 rabbit
anti-FMRFa
(Diasorin, Stillwater,
MN)
Through
metamorphosis
Olfactory nerve, tel,
suprachiasmatic hyp
(prometamorphic stage
56)
– (27)
NPFF and
receptors
Mouse Quantitive
autoradiogra-
phy
Radioligand: [125
I](1DME)Y8Famide
Post-natal Almost all brain areas at
P14
Pro-opioid (P14)
and anti-opioid
effect (P21) of
NPFF
(28)
NPFF Rat ISH, qPCR – E14-birth Spinal cord, medulla
(caudal NTS; E14), MRF
(P0), pituitary
Sensory
projection
development in
MRF, lactrotrope
differentiation?
(18)
NPFF Rat ir Pol rabbit anti rat
F8Fa (FLFQPQRF)
E16, E18, E20,
and post-natal
Fibers in median
eminence (E20), cells in
medulla (P1)
Role in
homeostatic
mechanisms,
food intake in
neonatals?
(17)
FMRFa
(NPFF+ ?)
Tree shrew
(Tupaia
belangeri )
ir on pituitary Pol 1:1000 rabbit
anti-FMRFa (Incstar,
Stillwater, MN, USA)
E20–E41 Pars intermedia of
pituitary from E27
Involved in early
hormone
secretion and
releasing factor
regulation?
(29)
FMRFa
(NPFF+ ?)
Tree shrew ir Pol 1:1000 rabbit
anti-FMRFa (Incstar,
Stillwater, MN, USA)
E19–E43 Developing TN from
E23
– (30)
The brain areas are generally named according to the original article. α-MSH, α-melanocyte-stimulating hormone; dpf, days post-fertilization; E, embryonic day; hpf,
hours post-fertilization; hyp, hypothalamus; ir, immunoreactivity; ISH, in situ hybridization; M, monoclonal; MRF, medullary reticular formation; NAPv, anterior periven-
tricular nucleus; NPP, periventricular preoptic nucleus; NPPv, posterior periventricular nucleus; NTS, nucleus of the solitary tract in medulla; OB, olfactory bulb; P,
post-natal day; Pol, polyclonal; qPCR, quantitative PCR; tel, telencephalon.
of reproduction in lower vertebrates (31). In adult teleost fishes,
NPFF seems to be exclusively expressed in gonadotropin releasing
hormone 3 (GnRH3) neurons of the terminal nerve (TN) that
stretches parallel to the olfactory nerve from the olfactory organ
to the nucleus olfactoretinalis in the telencephalon (14). The TN,
also known as the cranial nerve 0 (or N), was first described in
sharks over 100 years ago, and later it has become clear that most
vertebrates possess this nerve, from teleosts to primates, although
the function is still not fully understood (32). One characteris-
tic of these cells is that they express one variant of GnRH (32),
which, as mentioned above, is GnRH3 in fish. The TN cell bodies
are located parallel to the olfactory nerve, through the olfactory
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bulb to the telencephalon, but their axons project throughout the
brain, affecting many different behaviors, especially reproduction-
related behavior (33–35). Since it has been shown that NPFF can
inhibit pacemaker activity of TN GnRH-cells, NPFF is believed to
be involved in the regulation of reproductive behavior in fishes
(36). In amphibians, NPFF-immunoreactive (NPFFir) cells have
been identified in the preoptic area and hypothalamus (primar-
ily the suprachiasmatic region), and extensive networks of NPFFir
fibers are found throughout the brain, such as in the telencephalon,
hypothalamus, medulla, and dorsal spinal cord (15, 37–39). In
addition, many amphibians show NPFFir of the TN cells and
fibers, similar to the findings in fishes. However, there seem to
be species-specific variations regarding expression of NPFF in this
site in amphibians (40). To our knowledge, the roles of NPFF in
amphibians, reptiles, and birds are unknown. In rodents, NPFF cell
bodies have not been identified in anterior brain regions, but are
instead found in the hypothalamus, medulla, and spinal cord (41,
42). However, a dense network of NPFF fibers extends throughout
most of the brain, and also to the pituitary, suggesting that NPFF
can be involved in a range of different processes in mammals. In
addition, there seem to be species-specific differences in the loca-
tion of NPFF in mammals, since bovine cortex and hippocampus
contains NPFFir (43). The known effects of NPFF are very diverse
in mammals; most importantly NPFF has been found to act as a
neuromodulator in the opioid system, but has also been found to
increase arterial blood pressure, reduce water intake, inhibit the
release of vasopressin from the neurohypophysis, and influence
food intake (6, 44).
NPFF IN FISH DEVELOPMENT
In zebrafish (Danio rerio), NPFF expression first appears already
at 30 h post-fertilization (hpf; faringula period) in a small cell
cluster just ventral to the olfactory placode (in situ hybridiza-
tion) (14). The NPFF-positive cells co-express GnRH3, a marker
of ganglion cells of the TN. These cells are also marked with
FMRFa polyclonal antibodies, both in 30 hpf zebrafish embryos
and juvenile sturgeon (sterlet, Acipenser ruthenus) (19), as well as
in early embryos of trout (Salmo trutta fario) (20) and lungfish
(Neoceratodus forsteri) (21). However, in the latter three stud-
ies, at least one additional cluster of cell bodies was marked with
FMRFa immunoreactivity (FMRFir), situated in the diencephalon
(more specifically, the periventricular hypothalamus in zebrafish
and trout, circumventricular regions of hypothalamus in sterlet,
and the paraventricular organ in lungfish). These cells were not
labeled with in situ hybridization in zebrafish. Thus it seems that
the FMRFa polyclonal antibodies bind one or several other RFa
in addition to NPFF, making it challenging to interpret immuno-
histochemical data for FMRFa (14, 19). At 2 dpf, NPFF-expressing
cells are breaking off from the small cell cluster near the olfactory
placode and start caudal migration, forming a chain along the
TN trajectory in zebrafish (in situ hybridization) (14). This pat-
tern is also seen with FMRFa-immunohistochemistry in zebrafish,
sturgeon, and lungfish (19, 21), and is proposed to visualize a
migration route for cells of the TN from the olfactory placode to
the nucleus olfactoretinalis in the telencephalon (19). The origin
of the TN cells was believed to be the olfactory placode, but more
recent studies done in zebrafish have shown that the cells of the
TN originate from the neural crest and then invade the olfactory
placode and later migrate from the olfactory placode area to ante-
rior brain regions (45, 46). The hypothalamus and the spinal cord
of the zebrafish did not show any NPFF-labeled cells with in situ
hybridization, neither in the embryo nor the adult (14). This pat-
tern seems to be in contrast to the pattern in other vertebrates,
where NPFF-expressing cell bodies can be found in other brain
areas during development (see NPFF in Amphibian, Reptile, and
Avian Development and NPFF in Mammalian Development).
NPFF IN AMPHIBIAN, REPTILE, AND AVIAN DEVELOPMENT
Similar to teleosts and lungfish, FMRFa-immunohistochemistry
labels neurons of the TN of African clawed frog (Xenopus laevis),
also during development. Using an anti-NPFF serum produced
in rabbit, Lopez et al. (15) observed NPFFir cells in the embry-
onic olfactory placode, which is attached to the developing telen-
cephalon at stage 40 in Xenopus. Later (stage 43),NPFFir cells could
also be seen in the ventral part of olfactory bulb, and the devel-
oping telencephalon, rostral to the anterior commissure. Similar
labeling of the developing TN is also found with less specific anti-
bodies for FMRFa in Xenopus (27) and also in other amphibians,
such as European green frog (Rana esculenta) (22) and toad (Bufo
bufo) (23), in the reptile skink (Chalcides chalcides) (24), and in the
birds Japanese quail (Coturnix japonicavia) (16) and chicken (25).
Similar to zebrafish, the cells of the TN in these studies migrate
from the olfactory placode, along the olfactory bulbs, to the telen-
cephalon. Destruction of the olfactory placode in the toad embryo
leads to elimination of FMRFa cells in the olfactory bulbs, ventral
telencephalon, and anterior preoptic area, but not the cells in the
hypothalamus (see next paragraph), showing that as in fish, the
NPFF neurons of the TN migrate from the olfactory placode (23).
Also in Japanese quail, the migration of FMRFa (F8Fa) neurons of
the TN is similar to fish and amphibians (16), showing that this is
an evolutionary conserved feature of the TN.
In contrast to the apparent situation in teleosts, the developing
and the adult brains of amphibians and birds show presence of
NPFF mRNA and protein also in brain areas other than the TN
(15, 16). The main population of NPFFir cells in Xenopus embryos
is found in the suprachiasmatic region in the hypothalamus, and
these cells appear earlier than the neurons of the TN (15). This area
projects to the intermediate lobe of the pituitary and is involved
in the control of body color in Xenopus through the control of
α-melanocyte-stimulating hormone (α-MSH) that stimulates the
melanophores in the skin (47). The suprachiasmatic cells were
immunoreactive very early in development (stage 30), before pro-
duction of α-MSH starts, suggesting that NPFF may be involved in
the control of melanotrope cell development (15). The hypothala-
mic neurons seem to innervate the tectum, torus semicirculris, and
tegmentum in the mesencephalon, and the innervation increases
during development in Xenopus (34). The suprachiasmatic region
is also labeled with FMRFa antibodies early in embryonic Xenopus,
toad, European green frog, and skink (22–24, 27, 39). Placodec-
tomy studies in both birds and amphibians have shown that this
population of cells has a different developmental origin than the
FMRFir TN cells (16, 23, 39, 48).
Interestingly, neurons in the nucleus of the solitary tract in
the medulla show NPFFir at an early stage in Xenopus (20). This
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area projects to the parabranchial region and the innervation is
involved in the control of feeding in mammals (49). The cell bod-
ies in the nucleus of the solitary tract seem to decrease in their
immunoreactivity during development, but the projection to the
parabranchial area persists and this area is heavily innervated with
NPFFir fibers when the tadpoles start feeding (15). Also in devel-
oping mammals, NPFF cells are found in the nucleus of the solitary
tract (see next section). At the climax of metamorphosis, NPFFir
cells are detected in the reticular formation of the brain stem (15),
also similar to findings in mammals. In the spinal cord, NPFFir
elements were detected early in development, first in rostral spinal
segments and later in the thoracic and upper lumbar segments.
Interestingly, the NPFFir intensity was higher in the Xenopus spinal
cord than in the adult, suggesting that NPFF has a developmental
role in spinal cord embryogenesis. At the end of metamorphosis,
the adult pattern of NPFFir structures in Xenopus is established
(15). The brain stem and the spinal cord is not labeled with FMRFa
antibodies in frog or toad (22, 23), but the skink shows FMRFir in
these locations during development (24).
In the Japanese quail, the first NPFFir (F8F) fibers appear in the
diencephalon (later hypothalamus) and the brain stem at embry-
onic stage (E) 6 (16). Later, also fibers in the olfactory nerve and
the septum are labeled. In later developmental stages (E12), fibers
and cell bodies are seen in the already mentioned areas in addition
to the olfactory bulb. The location of NPFFir cells is similar to
GnRHir cells.
NPFF IN MAMMALIAN DEVELOPMENT
Using an antibody against rat NPFF (F8F-amide), Kivipelto et al.
showed the presence of fibers and terminal-like structures as early
as E20 in the rat (Rattus norvegicus) (17). The labeling was seen in
the internal layer of the median eminence in hypothalamus,an area
important for control of pituitary hormone secretion. However,
no labeled cell bodies were detected anywhere in the brain at this
stage. At birth, NPFFir cells were found in the caudal part of the
medial nucleus of the solitary tract in medulla, parallel to findings
in Xenopus. As mentioned, this area is involved in control of feed-
ing through its innervation to the lateral parabranchial nucleus
(an area associated with feeding control) (50). In accordance with
the findings in Xenopus, a relatively dense area of NPFFir termi-
nals and fibers were found in the parabranchial nucleus in the rat
(17). In addition, fibers and terminals were found in numerous
other parts of the brain; for instance paraventricular hypothalamic
area, supraoptic nucleus,optic decussation,and the periventricular
hypothalamic area. Dense networks of fibers and terminals were
seen in the internal layer of median eminence and infundibular
stem. Further caudally, scattered fibers were found in the central
gray and the inferior colliculus. At post-natal day (P) 3, also some
cell bodies were found in the caudal spinal nucleus of the trigem-
inal nerve (which is the place all the pain and temperature fibers
from the face terminate) and the dorsal horn of the spinal cord.
By the age of 4 weeks, the distribution of immunoreactivity was
similar to adults, where cell bodies could be seen in the periventric-
ular area of the medial hypothalamus in addition to more intense
labeling of the previously mentioned areas (17, 51).
In an in situ hybridization study on developing rat, Niemi-
nen et al. (18) found expression of NPFF at E14, much earlier
than the presence of NPFF protein seen with immunohistochem-
istry [at E20; (17)]. E14 embryos showed NPFF expression in
the medulla and spinal cord (18). Later (E17), distinct neurons
expressed NPFF in the spinal cord, and at birth NPFF expression
was seen in neurons in the rostral nucleus of the solitary tract in the
medulla, similar to what was found with immunohistochemistry.
In addition, reticular nucleus (corresponding to lateral medullary
reticular nucleus in adult rats) was found to express NPFF at birth,
parallel to findings in developing Xenopus (15). This expression
was transient in the rat, indicating that NPFF may be involved
in development of the sensory trajectories passing through this
nucleus (18). Expression of NPFF was also seen in the pituitary
of the embryonic rat, but no NPFF-expressing cells were observed
here. Finally, NPFF expression was found in the developing lung
and spleen.
Using an NPFF radioligand, Desprat et al. showed the presence
of receptors for NPFF in regions of the developing mouse brain
and spinal cord involved in the analgesic effects of opiates (28).
During post-natal development, they found that NPFF affected
the morphine-induced analgesia in different ways in the neonatal,
but in adults NPFF had only anti-opioid effect. From birth, they
could detect binding of NPFF in the olfactory bulb, and from P7
in the ventral pallidum and nucleus ventral endopiriform in the
telencephalon. Also in the diencephalon in the nucleus reuniens
NPFF binding appeared at P7, and in the mesencephalon a few
binding sites was visible at birth. This study shows that the inter-
play between NPFF receptors and opioid receptors is established at
early stages in mice. However, embryonic stages were not studied,
so the pattern of NPFF binding in the early developing mouse is
not known.
Interestingly, the TN of the mammal tree shrew (Tupaia belan-
geri) shows FMRFir (30). This mammal is closely related to
primates. The FMRFir pattern was similar to the pattern in
fish, amphibians, reptiles, and birds, with FMRFa cells appear-
ing early in embryogenesis (E20) near the olfactory epithelium,
and later along the migrating route for the TN. Thus, it seems that
NPFF expression in the TN is a feature conserved from fishes to
mammals.
In summary, NPFF is detected early in embryonic development
in all vertebrates studied, see overview in Table 1. In fishes, it seems
to be exclusively expressed in the TN, also during development. In
amphibians, reptiles, birds, and mammals NPFF can in addition be
found in the suprachiasmatic region in hypothalamus at very early
developmental stages. In Xenopus and mammals, medullary retic-
ular formation also shows NPFF labeling in embryos. No function
has been demonstrated for NPFF during development, but its
expression pattern in the brain may suggest it could be involved in
development of neurons of the TN, and nerve circuits involved in
control of feeding.
PrRP GROUP
The PrRP group includes the peptides PrRP31 and PrRP20. A new
member of this family, C-RFa is found in Japanese crucian carp
(Carassius cuvieri), zebrafish, Xenopus, and chicken (Gallus gal-
lus), but this variant is not found in mammals (52). PrRP peptides
bind the receptor GPR10 (prolactin-releasing hormone receptor;
PRLHR; also named GR3), but they also bind NPFFR2. Three
www.frontiersin.org December 2014 | Volume 5 | Article 203 | 5
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sandvik et al. RFamide peptides in vertebrate development
different receptors for PrRP peptides exist in some vertebrates,
while only one is found in mammals [see receptor synteny in Wang
et al. (52)].
PrRP IN ADULT VERTEBRATES
It is believed that PrRP is involved in the control of pituitary func-
tion in fishes. Firstly, in many species of adult fishes, PrRP fibers
project to and terminate on prolactin-producing cells of the pitu-
itary. Secondly, C-RFa injections in rainbow trout and tilapia cause
release of prolactin and somatostatin (53–56). Furthermore, PrRP
cell bodies are found in the nucleus lateralis tuberis pars posteri-
oris in guppy (Poecilia reticulata), rainbow trout (Oncorhynchus
mykiss), and goldfish (Carassius auratus) (52, 56, 57), an area sug-
gested to be important for control of pituitary function in teleosts
(58). There seems to be some variation in PrRP expression between
species. Some fish species have PrRP cell bodies also in other brain
areas, while others do not seem to have PrRP fibers projecting to
the pituitary (57).
In mammals, PrRP was thought to act on the pituitary, because
of the high expression of its receptor GPR10 in the anterior pitu-
itary (59). Preliminary studies in rats showed that the peptide
could promote prolactin release from pituitary cells and from these
studies the peptide got its name (60). However, later studies have
shown that this pathway may not be physiologically relevant in
mammals. Instead, it has been shown that PrRP is involved in
control of food intake and energy balance in rats and mice, and
that it can affect the stress response by elevating circulating levels
adrenocorticotropic hormone (ACTH) (59). Further, it has been
shown that PrRP has an effect on the cardiovascular system and
on circadian rhythms in mammals. Interestingly, it has been sug-
gested that endogenously produced PrRP peptide has an autocrine
role in cell-cycle progression and growth (61), processes that are
closely linked to development. PrRP is expressed in the nucleus of
the solitary tract, ventrolateral medulla, and in the caudal portion
of the dorsomedial hypothalamic nucleus in adult mammals (59).
PrRP fibers are found in many areas of the forebrain, as in preoptic
area, periventricular nucleus of the thalamus, and in periventricu-
lar nucleus and paraventricular nucleus of hypothalamus (62). In
contrast to the situation in fish and amphibians, no PrRPir can be
detected in the median eminence or in the hypophysiotropic cells
of the hypothalamus (63, 64). In peripheral tissues, PrRP mRNA
is found in the adrenal gland, pancreas, placenta, and testis (59).
PrRP IN VERTEBRATE DEVELOPMENT
Very few studies have looked at the possible role of PrRP in devel-
opment. However, the few that exist show that this peptide is
expressed at an early stage in Xenopus (65), chicken (52), and
rat (18, 62).
In the teleost guppy, PrRPir cells were detected in the nucleus
lateralis tuberis pars posterioris in the hypothalamus already at the
day of birth (57). However, innervation of PrRP fibers to the pro-
lactin cells of the pituitary was not seen at birth day, but appeared
later. Earlier developmental stages were not investigated, so the
role of this peptide in teleost development is not clear.
In Xenopus, the expression of PrRP mRNA is detected at an
early stage (stage 54; measured with qPCR) (65). PrRP mRNA lev-
els were highest in early premetamorphic stages (stage 57), and
decreased during prometamorphosis. This coincides with pro-
lactin starting to appear in the pituitary. In the chicken pituitaries,
the PrRP receptor PrRPR1 was expressed at E8 (measured with
qPCR) (52), and the expression increased at later developmen-
tal stages (E12, E16, and E20). However, earlier stages were not
studied.
In rat, PrRP mRNA and PrRPir cells are found in the nucleus
of the solitary tract at E18, and in the ventral and lateral retic-
ular nucleus of the caudal medulla oblongata at E20 (62). The
hypothalamus first showed PrRP expression and PrRPir at P13.
Similar to sexually mature rats, P6 animals had PrRPir fibers
in paraventricular hypothalamic nucleus, periventricular hypo-
thalamic nucleus, medial preoptic area, basolateral amygdaloid
nucleus, dorsomedial hypothalamus, ventromedial hypothalamus,
periventricular nucleus of the thalamus, and bed nucleus of the
stria terminalis. However, also areas not showing PrRPir in the
adult had PrRP in the developing rat brain at P6 and P9, like
optic chiasm, dorsal endopiriform nucleus, cingulum, intermedi-
ate reticular nucleus, and caudal ventrolateral reticular nucleus.
This transient expression could indicate a role in development of
these brain areas.
The presence of mRNA of PrRP and its receptor GPR10 has
also been investigated with in situ hybridization in rat embryos in
a different study. Nieminen et al. (18) found a similar pattern as
shown with immunohistochemistry. However, they found expres-
sion of PrRP in the reticular formation at a much earlier stage
[E17 compared to P6 in (62)]. The receptor GPR10 was expressed
at very early stages; at E15 in the pallium, at E16 in the hippocam-
pus, and at E19 in the reticular formation. Interestingly, this is
before any PrRP mRNA can be detected in these locations (18,
62), which may suggest that the receptor has an alternative ligand.
In the pituitary, the expression of both PrRP and GPR10 starts at
E18, at the same time as the lactotrops first appear (18). This is
the opposite of the situation in Xenopus, where PrRP expression
decreases when prolactin starts to appear in the pituitary (65). In
the periphery, PrRP expression was seen in the developing liver,
and to some extent in the spleen and kidney (18).
Studies of PrRP in vertebrate development are summarized in
Table 2.
GnIH GROUP
GnIH was first described by Tsutsui et al. (67). This RFa was found
to inhibit gonadotropin release in the quail through binding to the
G-protein-coupled receptor GPR147. It has since been found that
in birds, GnIH can act directly on gonadotrope cells to inhibit both
synthesis and release of gonadotropins, e.g., Ref. (68–70). More-
over, it may also act on GnRH-neurons to inhibit GnRH release
and thereby indirectly inhibit gonadotrope cells [e.g., Ref. (71)].
Since its first discovery in birds, GnIH orthologs have been found
in most vertebrate classes [see review by Tsutsui and Ubuka (72)
and references therein]. Alternative names are sometimes used
in different vertebrate classes – the mammalian ortholog being
named RFa-related peptide (RFRP) with the RFRP gene encod-
ing two bioactive peptides, RFRP-1 (or NPSV) and RFRP-3 (or
NPVF) (73). The mammalian receptor is sometimes referred to as
NPFFR1 or NPFF1. In amphibians, GnIH is sometimes referred to
as GRP, GRP-RPs, or R-RFa [e.g., Ref. (74)], while in teleosts the
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Table 2 | Overview of studies of PrRP in vertebrate development.
RFa and/
or receptors
Species Method Antibody Embryonic
stages
Location of
peptide/mRNA
in early
developing CNS
Putative
functions
in early
development
Reference
PrRP Guppy
(Poecilia
reticulata)
ir Pol rabbit
anti-salmon PrRP
(56)
0-P14 Hyp, pituitary pars
distalis at birth
Developmental
role?
(57)
PrRP Xenopus
laevis
qPCR – Premetamorphosis-
climax (54–65)
Transiently increased
expression in brain at
prometamorphosis
– (65)
PrRP Chicken
pituitary
RT-PCR – E8–20 Expressed in pituitary at
all stages studied
– (52)
PrRP Rat ISH, RT-PCR,
ir
M 40µl/ml P2L-1C
(mature PrRP)/P2L-1T
(prepro-PrRP) mouse
anti human PrRP (66)
E15, E18, E20, and
post-natal
NTS (E18), MRF (E20),
hyp (P13)
Role in embryonic
brain
development?
(62)
PrRP+GPR10 Rat ISH, qPCR – E14-birth PrRP: MRF, pituitary
(E19), GPR10: pallidum,
hippocampus, and MRF
(E15–17)
Lactrotrope
differentiation?
(18)
The brain areas are generally named according to the original article. E, embryonic day; hpf, hours post-fertilization; hyp, hypothalamus; ir, immunoreactivity; ISH, in situ
hybridization; M, monoclonal; MRF, medullary reticular formation; NTS, nucleus of the solitary tract in medulla; P, post-natal day; Pol, polyclonal; qPCR, quantitative
PCR; RT-PCR, reverse transcription PCR.
term LPXRFa may be used [e.g., Ref. (75)]. In the following, we
will use the common name GnIH regardless of vertebrate class.
GnIH IN ADULT VERTEBRATES
In adult vertebrates, GnIH positive cells are found in different
regions of the brain, notably in hypothalamic regions like the avian
paraventricular nucleus, from where they send their projections to
GnRH1 neurons in the preoptic region or to gonadotrope cells in
the pituitary. GnIH terminals and GnIH receptors have also been
identified on GnRH2 neurons in birds and mammals, e.g., Ref. (71,
76). A recent paper shows that GnIH inhibits socio-sexual behavior
of male quail through a direct activation of aromatase and thereby
increased neuroestrogen synthesis in the preoptic area (77). Both
GnIH and its receptor are also expressed in the pituitary in dif-
ferent vertebrate classes, indicating auto- or paracrine regulation
[e.g., Ref. (78)]. In addition, various studies have revealed GnIH
positive cells in the gonads (both testis and ovary), while PCR
experiments have revealed gene expression in peripheral tissues
like muscle, spleen, eye, and kidney [e.g., Ref. (79)]. The expres-
sion of both ligand and receptor in the avian gonads (80) again
points to an auto- or paracrine role during gametogenesis.
The spatial expression pattern should indicate potential func-
tions, although much remains to be discovered when it comes to
GnIH functions in general and during development in particular.
Similar to in birds, GnIH in mammals have been shown to inhibit
gonadotropin synthesis and release, either directly in the pituitary
or via inhibition of hypothalamic GnRH-neurons. The situation
seems different in frogs and teleost fish where GnIH can either
inhibit or stimulate gonadotropin (and also growth hormone and
prolactin) release, depending on reproductive stage, species, and
sex, e.g., Ref. (74, 79, 81–84). Also in an agnathan species (sea lam-
prey; Petromyzon marinus), GnIH stimulates expression of GnRH
and gonadotropin β-subunit (85), indicating that this neuropep-
tide may have experienced a shift in function during vertebrate
evolution.
As most interest has focused on its role as an inhibitor of GnRH
and gonadotropin release during reproduction, very little is known
about GnIH during vertebrate development. Apart from some
studies looking at pre-pubertal stages, the information we have is
mostly limited to studies on the spatio-temporal expression pat-
tern in mammalian and avian (post-natal) development, and some
very few in teleost early development.
GnIH IN VERTEBRATE DEVELOPMENT
A recent article from Biswas and colleagues (78) provided some
interesting information regarding the spatial expression pattern
of GnIH peptides in Indian major carp (Labeo rohita), although
detailed origin of their antibodies are missing from the paper.
For instance, they found GnIH expression in the olfactory system
(epithelium and bulb) in newly hatched larvae, indicating a non-
reproductive function. Expression in hypothalamic nuclei such as
the periventricular preoptic nucleus and the posterior periven-
tricular nucleus, usually related to gonadotropin regulation in the
adult, were also found in newly hatched larvae of the Indian major
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carp. Moreover, GnIH was found expressed in the anterior part
of the carp pituitary [rostral pars distalis (RPD) and proximal
pars distalis (PPD)] already from hatching, although no staining
could be found at the adult stage, again pointing to an autocrine
or paracrine function. Another recent study provides information
of the temporal gene expression pattern of GnIH and its recep-
tors during zebrafish early development (79). Whereas each of the
three GnIH receptor paralogs could be found expressed (RT-PCR)
already at the blastula stage and all the way through to the adult
stage, although with differential expression patterns, the GnIH
ligand was found only from a later embryonic stage; at 24 hpf
(early pharyngula period). Nevertheless, these results indicate a
functional GnIH ligand/receptor system active already from early
embryonic stages in zebrafish. This is supported by recent results
from our own lab, where we find expression of medaka (Oryzias
latipes) gnih and gnihr1 already from 1 hpf and throughout the
larval period, indicating maternal transfer in medaka (own unpub-
lished data). The other two receptor paralogs in medaka, gnihr2
and gnihr3 were also expressed from early stages and throughout
the larval period, although not until after the mid-blastula transi-
tion. The expression profile of medaka gnih resembled that seen in
GnIH neurons in post-natal mice (86) with an initial increase fol-
lowed by a steady decrease in expression levels. There is no existing
data on the spatial expression of GnIH ligand or receptor during
early development in fish.
In birds, where GnIH was first characterized, the existing
literature focuses on the function of the GnIH system during
sexual development, especially during the pre-pubertal period.
For instance, circulating gonadotropin levels have been found
to be negatively correlated with hypothalamic GnIH content
(87). In immature male quail, chronic injections of GnIH sup-
pressed normal testicular development, including reduced plasma
testosterone levels and suppression of germ cell proliferation and
seminiferous tubule development (70).
As mammalian model systems are less suited for studies of
early embryogenesis, the few papers dealing with GnIH in mam-
malian development starts from late gestational stages. Yano et al.
(88) found both GnIHs (RFRP-1 and -3) expressed in rat fetal
hypothalamus from E15–E16 (mRNA) and embryonic day 16–17
(protein), showing first evidence of the existence of a functional
system at the fetal stage also in mammals. Using a combination
of GnIH in situ hybridization and BrdU immunohistochemistry,
Legagneux et al. (89) identified GnIH producing neurons in male
and female rat exclusively in the tuberal hypothalamus. These neu-
rons to a large extent developed early, around E13–E14. In male
and female rats, both Quenell et al. (90) and Iwasa et al. (73) found
progressive gene expression of both GnIH and its receptor from
early post-natal stages (from 4 days) all the way through puberty to
the adult stage. Iwasa et al. also measured GnIH peptide levels and
found a profile similar to that of GnIH gene expression, suggesting
that the GnIH system indeed is active and plays a role during sexual
development in rats (73). In accordance with these results, Poling
et al. (86) also detected early gene expression of GnIH. mRNA
levels increased in both sexes during post-natal and pre-pubertal
development, before a decline was seen between post-natal day
20 and adulthood. During development in male rats, sustained
knockdown of GnIH led to increased plasma levels of LH and
increased testicular growth (91). These data indicate that GnIH act
as inhibitor of gonadal maturation and puberty, similar to the sit-
uation in birds. However, Iwasa et al. (73) found increased GnRH
gene expression levels concomitant with increased GnIH ligand
and receptor expression during development in rat. This suggests
that GnIH alone is not sufficient as inhibitor, but that regula-
tion of sexual development is more complex, probably including
additional factors such as other RFa, in addition to energy-related
factors like ghrelin or leptin, or other.
In summary, the expression of a seemingly functional GnIH
system in fish, birds, and mammals already from early develop-
ment suggests important developmental function(s) of this RFa in
vertebrates. If these include more than the above mentioned reg-
ulatory (inhibitory/modulatory) effects on sexual development,
remains to be seen. See Table 3 for an overview over developmental
studies of GnIH.
KISSPEPTIN GROUP
Kisspeptins are RFa encoded by the Kiss gene. The resulting pro-
tein is further processed into bioactive peptides of variable lengths
(94), while their receptors belong to the rhodopsin family of
G-protein-coupled receptors (95–98).
KISSPEPTIN IN ADULT VERTEBRATES
The product of the Kiss gene was first discovered as a metas-
tasis suppressor and therefore termed metastin (99). However,
kisspeptins and their putative receptors (Kissr or Gpr54) have dur-
ing the last decade emerged as major gatekeepers of reproduction
because of their central role in regulating the brain–pituitary–
gonadal (BPG) axis [reviewed by Ref. (100)]. The importance
of the Kiss system as a regulator of the BPG-axis came after
observations that mutations in the Gpr54-1 lead to idiopathic
hypogonadotropic hypogonadism (101, 102). Besides its role as
a tumor suppressor and regulator of the BPG-axis, several studies
report additional roles of the Kiss system, including vasocon-
striction (103, 104), neuronal migration, and increased synaptic
transmission (105, 106). For example, Fiorini et al. (107) showed
that stimulation with KISS increased neurite growth in GnRH-
positive neurons in vitro. Although detailed mechanisms of action
are still lacking, these seemingly pleiotropic roles may reflect the
diversity of intracellular signaling pathways that can be triggered
by Kiss receptor activation (100, 108). The current understanding
in mammalian systems suggests that major endogenous and envi-
ronmental signals act through Kiss neurons, which then directly
or indirectly provide an integrated signal to the hypophysiotropic
GnRH neurons.
KISSPEPTINS DURING DEVELOPMENT
Despite the accumulating data of the role of kisspeptins in
adult vertebrates, less is known about kisspeptins during post-
natal/pre-pubertal development, and very little is known regarding
the potential expression and function of the kiss system dur-
ing embryogenesis/early development. This could at least partly
be due to the lack of a suitable model system. Because Kiss or
Gpr54 KO mice are infertile, homozygous offspring need to be
established from heterozygous parents. This means that the pos-
sibility of maternal transfer of transcripts, including those of Kiss
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Table 3 | Overview of studies of GnIH in vertebrate development.
RFa (and/
or receptors)
Species Method Antibody
(or radioligand)
Embryonic
stages
Location of
peptide/mRNA
in early
developing CNS
Putative
functions
in early
development
Reference
GnIH Indian
major carp
(Labeo
rohita)
ir ? Hatchling-fry-
juvenile
Cells in olfactory
system, NPP, NPPv, and
fibers in optic tectum,
PPD in pituitary, and
MRF (P0)
– (78)
GnIH+
receptors
Zebrafish
(Danio
rerio)
RT-PCR - Blastula-juvenile GnIH first detected at
5-prime stage,
receptors at all stages
Role in early
development?
(79)
GnIH Rat ISH, RT-PCR,
ir
M 10µg/ml 1F3
anti-RFRP-1, P
16µg/ml antisera
anti – FRP-1 (92, 93)
E15, E18, E20, and
post-natal
Caudal portion of hyp
(E16), many areas at
E18 and E20
Modulation of
pain, response to
stress during
development?
(88)
GnIH and
GPR147
Rat qPCR,ELISA Pol rabbit anti-avian
GnIH (67)
Pre-pubertal (P4–20)
and peripubertal
GnIH and receptor
mRNA and peptide
present in hyp from P4
– (73)
GnIH Rat ISH+BrdU – Cell bodies generated at
E13/E14 in tuberal hyp
– (89)
GnIH Mouse ISH – P1, P10, P20 mRNA and protein in
dorsal-medial nucleus
of hyp from P1
– (86)
The brain areas are generally named according to the original article. E, embryonic day; hyp, hypothalamus; ir, immunoreactivity; ISH, in situ hybridization; M, mono-
clonal; NPP, periventricular preoptic nucleus; NPPv, posterior periventricular nucleus; P, post-natal day; Pol, polyclonal; PPD, proximal pars distalis in adenohypophysis;
qPCR, quantitative PCR; RT-PCR, reverse transcription PCR.
and Gpr54, cannot be excluded in this system. Furthermore, and
common to all RFa families discussed here, studying embryonic
development in mammals in vivo is difficult due to their viviparity.
The few existing data on kisspeptins during early develop-
ment come from studies in medaka and zebrafish. We recently
performed a study of kisspeptin ligand and receptor expres-
sion pattern and function during early development in medaka,
exploiting the advantages of the teleost model system (109). qPCR
gene expression profiles (Figure 1) revealed maternally provided
Kiss systems involving the two kiss ligands (kiss1 and kiss2) and
one of the receptors (gpr54-1), indicating the possibility of func-
tional Kiss receptor-ligand systems at very early stages. gpr54-2, on
the other hand, was not detected until after the zygotic phase, at
stage 15, with a significant increase in expression levels between
stage 30 and stage 36. In zebrafish, kiss1 and kiss2 gene expres-
sion was reported in 24 hpf (30 somite stage) embryos (110), but
earlier stages were not investigated. In another teleost, the cobia
(Rachycentron canadum) gpr54-1 expression was detected at 1 day
post hatching (111). The early expression of kiss and gpr54 also
coincides with the early expression of gonadotropins in fish (112),
indicating a potentially functional BPG-axis already during early
embryogenesis.
In Hodne et al., we performed a series of knockdown exper-
iments that indicated several independent kiss systems during
medaka embryonic development (109). Both maternally and
zygotically expressed kiss1 and gpr54-1 seemed critical for proper
development (Figure 2). However, the apparent functions of
the maternally and zygotically expressed transcripts were quite
distinct, as explained below.
Knockdown of maternal kiss1 and gpr54-1 led to developmental
arrest and subsequent death around the blastula stage (stage 10–
11), suggesting that this early expressed system could be involved
either in regulation of early asynchronous cell division or early cell
migration. The downstream factors controlled by kiss1/gpr54-1
signaling are not known. However, cell migration during blastula-
tion and gastrulation is dependent on sdf1/cxcr4 chemotaxis. This
signaling pathway is also known to be important during bone-
directed migration of GPR54-positive breast cancer cells (113)
and kisspeptin can indirectly regulate sdf1/cxcr4 through desensi-
tization of cxcr4 by preventing rise in intracellular Ca2+ levels after
sdf1 stimulation (114, 115). In zebrafish, knockdown of sdf1/cxcr4
inhibits migration of endodermal cells during gastrulation (115).
Moreover, sdf1 signaling is crucial for survival in mice, and individ-
uals lacking either receptor or ligand have defective hematopoiesis,
www.frontiersin.org December 2014 | Volume 5 | Article 203 | 9
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sandvik et al. RFamide peptides in vertebrate development
FIGURE 1 | Kiss and kiss receptors are expressed at very early
stages in medaka embryos. Relative gene expression of kiss1
(A), kiss2 (B), gpr54-1 (C), and gpr54-2 (D) was analyzed at
different developmental stages (mean±SEM; n=7). Key
developmental stages are given above the age of the hours (h) or
days (d) post-fertilization (hpf). The gene expression levels are given
relative to a reference gene (β-actin). Different letters indicate
significant differences (P <0.05). Figure from Ref. (109).
developmental lymphoid tissue, vascularization of gastrointesti-
nal tract, migration of neuronal cells, and patterning in the central
nervous system, and they die prenatally (116, 117).
Zygotic knockdown of kiss1 and gpr54-1, on the other hand,
allowed the embryos to survive gastrulation and a seemingly
normal development continued until completion of neurula-
tion (stage 18). At this point, early eye development is normally
observed. However, after zygotic knockdown with either mor-
pholino or low dose of peptide nucleic acid (PNA), eye develop-
ment was interrupted, and further brain development was severely
disrupted (Figure 2). Surprisingly, knockdown of kiss2, which was
expressed at similar levels as kiss1, did not produce any increased
mortality or malformed embryos. Unless kiss1 takes over the role
of kiss2 following kiss2 knockdown, kiss2 does not seem to be
critical for proper development. If kiss2 is translated and active
before zygotic activation, our results indicate that it does not work
through gpr54-1 (which is not expressed at this point), but possi-
bly through gpr54-2 (although knockdown of this receptor leads
to developmental arrest and 100% mortality), or through other,
currently unknown, RFa receptors. The different effects observed
following kiss1 and kiss2 knockdown suggest the possibility of a
very early separation of two functional systems during embryonic
development. One system, comprised of Kiss1 and Gpr54-1, has a
functional role important for survival during the maternal stage
of development. This system continues to function throughout
embryonic development, although it seems more important for
regulating brain development at later embryonic stages. A second
system seems to be comprised of Kiss2 binding to either Gpr54-2
or other unknown RFa receptors. The possible function of this
second system remains to be clarified.
Contrary to the observed phenotypes following zygotic knock-
down of kiss1 and gpr54-1 outlined above, a moderate knockdown
of medaka gpr54-2 arrested further development at stage 16 (late
gastrula). This phenotype resembled that of maternal kiss1 and
gpr54-1 knockdowns. However, as gpr54-2 is first detected after
transition to zygotic gene expression, new questions arise as to
why a similar phenotype was not also observed after zygotic kiss1
and gpr54-1 knockdown. One explanation could be that the two
receptors are functionally separated. If they are involved in similar
functions, our results indicate that the actions of Gpr54-1 may be
partly compensated for by Gpr54-2, whereas Gpr54-2 cannot be
functionally replaced by Gpr54-1.
A recent work by Zhao et al. has investigated the role of kiss
on GnRH neuron development in zebrafish (118). In line with
Kitahashi et al. (110), kiss1 and kiss2 mRNA could be detected by
qPCR from 24 hpf. Furthermore, it was shown that both kiss lig-
ands stimulated GnRH3 neuron proliferation peripherally, while
only kiss1 stimulated proliferation and synaptic contact points of
GnRH3 neurons in the TN and hypothalamic regions.
The existence of a functional kisspeptin system in birds is not
clarified [see in Ref. (119)], and consequently, there are no data on
this during bird development.
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FIGURE 2 | Low dose antisense knockdown (KD) lead to impaired brain
and eye development. kiss1 knockdown embryos showed impaired eye
development at 1 dpf (top right). At 3 dpf, there was no development of the
forebrain after kiss1 knockdown (bottom right). Scale bars correspond to
50µm (top images) or 100µm (bottom images). Arrowheads point to the
area of the developing eyes. Figure from Ref. (109).
In mammals, the kisspeptin system has been intensively inves-
tigated during the last decade. Whereas, most literature covers
the key role of Kiss in regulating GnRH neuron around and after
puberty, pre- and early neonatal stages have been looked into more
closely during recent years [see reviews in Ref. (120, 121) and
references therein]. For instance, Kiss1 gene expression has been
detected in hypothalamic areas during the late fetal period in mice
[stage E13.5; (122)] and both gene expression and peptide have
been detected in rats [stage E14.5, (123)]. There are two hypo-
thalamic areas expressing Kiss; the arcuate nucleus (ARC), and the
preoptic AVPV (anteroventral periventricular nucleus) and PeN
(rostral periventricular nucleus). Whereas, Kiss neurons appear in
the ARC prenatally, Kiss expression in the AVPV/PeN is not seen
until neonatal stages. There seems to be clear sex differences in the
expression of Kiss in rodents, with females expressing higher lev-
els than males in both the ARC and the AVPV/PeN. Gpr54-1 gene
expression has also been detected in stage E13.5 prenatal mice
(122), indicating the possibility of a functional ligand–receptor
system from this stage on. Also in second trimester human fetuses,
KISS and GPR54 immunoreactivity was detected in the hypothala-
mus. Maternally provided Kiss ligands or receptors have, however,
not been reported.
It seems that the early kisspeptin systems are functional in
rodents in that Kiss neurons already are in close contact with
GnRH-neurons prenatally, and that GnRH-neurons are able to
respond to kisspeptins by enhanced GnRH secretion during
prenatal life (120, 122, 124, 125). Based on these and several other
studies, a more generalized picture is starting to appear with a
seemingly functional kisspeptin system in place during the last
part of gestation. The Kiss neurons increase in number and activ-
ity and reach a peak prenatally, before a decreased activity around
birth, and then a new increase again during early neonatal life
before the activity decreases to low levels until the pre-pubertal
stage. The prenatal and early neonatal peaks in Kiss neuron activ-
ity seemingly coincide with similar peaks in GnRH and pituitary
gonadotropin secretion [see in Ref. (120, 121, 126–132)]. However,
the function of this early expression of Kiss remains elusive.
In line with the more severe phenotypes observed in medaka
following receptor knockdown (109), Lapatto et al. (133) also
described a more severe phenotype following Gpr54-1 knockout-
compared with Kiss1 knockout mice. As mice possess only the
one Gpr54 paralog, one of several suggestions was a possible weak
activation of Gpr54-1 by other ligands. The results of Hodne et al.
(109) and those of Lapatto et al. (133) suggest that Kiss and possi-
bly other RFa may promiscuously bind to different RFa receptors
[see also in Ref. (134–136)]. Interestingly, Mayer and Boehm (137)
found that female mice with genetically ablated kisspeptin neurons
underwent puberty and became fertile. In contrast, acute abla-
tion in adult mice inhibited fertility. These results clearly indicate
compensatory mechanisms for early loss of kisspeptins. Whether
maternally transferred kiss is crucial for mouse development has
not been investigated.
Although more data are available regarding the role of
kisspeptins during vertebrate development compared to the role
of other RFa, there are still much work to be done. One important
aspect probably will be to elucidate their role in neuronal migra-
tion/development, where they seemingly play a major role, at least
in fish. See Table 4 for an overview over developmental studies of
kisspeptins.
26RFa/QRFP GROUP
The 26RF/QRFP group is the newest member of the RFa fam-
ily, first described in 2003 in the brain of European green frog
(140). The gene for 26RFa/QRFP is found in genomes of many
species, from teleost fish to human, with preserved synteny in
human, mouse, chicken, and Xenopus (4). Mature peptides gen-
erated from this gene are 26RFa, 43RFa in rat, mouse, human,
and frog, 9RFa in human and frog, and 26RFa and 7RFa in fish
(4, 141). 26RFa/QRFP binds the receptor GPR103/26RFaR (142,
143). In addition, the peptide has affinity for NPFFR2 (144).
26RFa/QRFP IN ADULT VERTEBRATES
In adult goldfish, 26RFa/qrfp mRNA is found in the hypothala-
mus, optic tectum-thalamus, and testis (141). Because the expres-
sion in the hypothalamus was significantly reduced after 4 days
of starvation, and intraperitoneal injections of the 26RFa/QRFP
peptide increased LH levels, 26RFa/QRFP has been suggested to
play a role in the regulation of energy homeostasis and regula-
tion of the BPG-axis in fish (141). Also in birds, 26RFa/QRFP
is expressed in the diencephalon; in the anterior hypothalamic
nucleus in chicken, and in the anterior-medial area, the ventro-
medial nucleus and the lateral hypothalamic area in zebra finch
(Taeniopygia guttata), areas involved in hypothalamic control over
feeding behavior (145, 146). The findings are similar in mammals,
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Table 4 | Overview of studies of kiss in vertebrate development.
RFa (and/or
receptors)
Species Method Antibody Embryonic
stages
Location of
peptide/mRNA
in early
developing CNS
Putative
functions
in early
development
Reference
Kiss Zebrafish
(Danio rerio)
qPCR, kiss
treatment,
electrophysi-
ology
– 1–7 dpf Kiss1 and 2 mRNA
detectable in brain from
1 dpf, increasing during
development
Kiss1 stimulates
GnRH neuron
development,
Kiss2 involved in
development of
trigeminal
neurons
(118)
Kiss Zebrafish qPCR – 1, 3, 7, 30, 45 dpf,
adult
kiss1 and kiss2
detected from 1 dpf
– (110)
GPR54 Cobia
(Rachycentron
canadum)
qPCR – Post
hatching-adult
gpr54 present at all
stages
– (111)
Kiss and
receptors
Medaka
(Oryzias
latipes)
qPCR+
knockdown
– From fertilization
to newly hatched
– Essential for brain
and eye
development
(109)
Kiss Rat qPCR, ISH ir,
BrdU birth
dating
Pol sheep anti-kiss
(N-ter) AC067
Embryonic rats
from E11.5 to
E21.5
Kiss1 neurons in
arcuate nucleus born
from E12.5
Involved in
embryonic
activation of the
hypothalamic–
hypophyseal–
gonadal
axis
(123)
Kiss Rat ISH – Post-natal
(neonate to adult)
Anteroventral
periventricular nucleus
(P7 in males, P21 in
females), arcuate
nucleus (P3)
– (131)
Kiss Rat ISH – Post-natal
(P0–P19)
Anterior hyp (P11),
arcuate nucleus (P0)
Role in sexual
differentiation of
neonatal brain
(130)
Kiss Rat Kiss
stimulation
(in vivo and ex
vivo)
– Post-natal – Stimulating GnRH
release in
neonatals (5P)
(126)
Kiss+GPR54 Rat qPCR on hyp – Post-natal
(P1–75)+ adults
Kiss and Gpr54 present
at all stages
– (138)
Kiss+GPR54 Mouse Transgenic
mice
– E12.5, E13.5,
E14.5, and E16.5
Kiss: arcuate nucleus in
hyp (E13.5), Gpr54:
restricted to
GnRH-neurons in
anterior forebrain
(E13.5-post-natal)
Regulating fetal
GnRH activity?
(124)
(Continued)
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Table 4 | Continued
RFa (and/or
receptors)
Species Method Antibody Embryonic
stages
Location of
peptide/mRNA
in early
developing CNS
Putative
functions
in early
development
Reference
Kiss+GPR54 Mouse RT-PCR, kiss
treatment++
E12.5, E13.5,
E14.5, and E15.5
Kiss1: mediobasal hyp
(E13.5), Gpr54: preoptic
area (E13.5)
Stimulates GnRH
neurite growth
(107)
Kiss+GPR54 Mouse ISH, qPCR, ir Pol 1:10000 rabbit
anti-rodent-kiss 1
(139)
E13, E15, E17 to
P35
Kiss1: near median
eminence (E13);
preoptic periventricular
nucleus (P12), Gpr54:
from nasal
compartment to
forebrain in migrating
GnRH-neurons (E13)
Involved in sexual
differentiation of
the brain during
embryonic
development?
(132)
GPR54 Mouse ISH, single
cell qPCR,
Ca2+ imaging
– E12.5, E13.5,
E14.5, E17.5, and
adult
In GnRH-cells in nasal
region and nasal
forebrain junction
(E13.5)
– (122)
Kiss Mouse ir Pol 1:5000 rabbit
anti-kisspeptin-10
(no. 566) (139)
Post-natal-adults
(P10–P61)
Anteroventral
periventricular nucleus,
preoptic periventricular
nucleus in hyp (P25)
and arcuate nucleus in
hyp at all stages
Kiss neurons in
anteroventral
periventricular
nucleus and
preoptic
periventricular
nucleus in hyp
involved in the
sexually
differentiated
functioning of
GnRH-neurons
(127)
Kiss Mouse ISH – Post-natal
(P1–P16)
Anteroventral
periventricular nucleus
and preoptic
periventricular nucleus
in hyp from P10
Involved in the
sexually
differentiated
functioning of
GnRH-neurons
(129)
Kiss Mouse ir Pol 1:10000 rabbit
anti-kisspeptin-10
(no. 566) (139)
Post-natal (P15–
P30)+ adults
Preoptic periventricular
nucleus in hyp from P15
– (128)
The brain areas are in general named according to the original article. dpf, days post-fertilization; E, embryonic day; hpf, hours post-fertilization; hyp, hypothalamus; ir,
immunoreactivity; ISH, in situ hybridization; P, post-natal day; Pol, polyclonal; qPCR, quantitative PCR; RT-PCR, reverse transcription PCR; tel, telencephalon.
where the presence of 26RFa/QRFP has been shown in regions that
are important for regulation of food intake and energy homeosta-
sis. In rodents, high levels of 26RFa/QRFP are found in dorsolateral
and mediobasal hypothalamic areas, and in humans 26RFa/QRFP-
cells are found in the paraventricular and ventromedial nuclei of
the hypothalamus (140, 144, 147). It has been found that injec-
tions of 26RFa/QRFP have an orexigenic effect (increased food
intake) in rodents (148). 26RFa/QRFP has also been found to
affect aldosterone secretion, insulin secretion, adipogenesis, bone
formation, nociceptive transmission, blood pressure and, as in fish,
to stimulate pituitary hormone secretion in mammals (4).
26RFa/QRFP IN DEVELOPMENT
The developmental expression of 26RFa/QRFP and GPR103 has
only been studied in human adrenal gland and rat adrenals (149).
Both the receptor and ligand were present from early stages of
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adrenal development, mostly expressed in the adrenal cortex, but
also in the medulla in human fetus. Some clues for the poten-
tial role of 26RFa/QRFP in development are also obtained from
knockout studies of the receptor for 26RFa/QRFP in mice (150).
Homozygous mice was viable, but they suffered from osteopenia
(reduced bone density), and the investigations suggested that the
bone formation was arrested at an early stage. It remains unclear if
this effect is due to lack of hypothalamic signaling of 26RFa/QRFP,
because mRNA of the receptor is found in bone and in osteoblast
cell lines in addition to the hypothalamic expression (150). The
knockout mice seemed to behave normally and were fertile. How-
ever, studies of the brain and the behavior of the animals was
not included in the paper, thus it is unknown if knockout of the
26RFa/QRFP receptor can affect specific behaviors.
CONCLUSION
The RFa form a complex family with many different members
acting in various physiological processes, with one peptide seem-
ingly having several functions in the same animal in some cases.
Common to all the peptides seems to be that they could have a
role in appetite regulation, pain modulation, and reproduction.
With the newest member of the RFa family found only a little over
10 years ago, the field of RFa is relatively new and requires much
more research. Especially, how these peptides can influence devel-
opment is poorly understood. However, the few studies of RFa in
developing vertebrates show interesting results that may indicate
that many of the RFa could have a separate role in development.
Interestingly, it seems that all RFa are expressed early in devel-
opment in many different groups of vertebrates. However, most
of our knowledge of RFa comes from in situ hybridization and
immunohistochemistry experiments. Very few functional studies
have been conducted, so it is difficult to assess the role of this early
expression. One knockdown study on medaka performed in our
laboratory shows that kiss1, gpr54-1, and gpr54-2 play vital roles
in early development in this fish species, and that these genes are
probably important for proper brain development. It will be very
interesting to see if loss or gain of function could reveal novel
functions of the other RFa.
The cellular pathways of RFa are poorly understood, and more
research is required to find out how RFa can act on developmental
processes. However, some RFa (26RFa and Kiss) have been shown
to affect migration in cancer cells (114, 151). RFa may also be
important for the proper migration of neurons in the developing
brain. However, more research is needed to clarify the role of RFa
in neuronal migration. Another interesting aspect of RFa is the
fact that many of them can affect apoptosis and cell-cycle pro-
gression, possibly through affecting opioid receptors (152). PrRP
is also found to influence human lymphocyte proliferation (153).
In invertebrates, FMRFa has been found to inhibit apoptosis in a
snail, indicating that the link between RFa and apoptosis is an evo-
lutionary conserved mechanism (154). Interestingly, NPFF gene
expression in mammals is regulated by transcription factors also
involved in cell-cycle regulation and apoptosis (155).
The field of RFa in vertebrates is exiting and rapidly expanding.
The few developmental studies that have been done show promis-
ing and important results. Taken together, these studies indicate
that RFa may have a role in development of the nervous system
not yet identified. More research is needed, especially functional
studies that can give insight into the role these peptides play in
development.
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